Impact of quercetin on systemic levels of inflammation: a meta-analysis of randomised controlled human trials
Impact of quercetin on systemic levels of inflammation: a meta-analysis of randomised controlled human trials
Ou et al., 2020 | Int J Food Sci Nutr | Meta Analysis
Citation
Ou Qiaowen, Zheng Zhifen, ... Lin Weiqun. Impact of quercetin on systemic levels of inflammation: a meta-analysis of randomised controlled human trials. Int J Food Sci Nutr. 2020-Mar;71(2):152-163. doi:10.1080/09637486.2019.1627515
Abstract
Knowledge regarding the anti-inflammatory capability of quercetin remains inconclusive and controversial due to the heterogeneous methods and inconsistent results of RCTs. We performed a series of meta-analyses of RCTs to evaluate the impact of quercetin supplementation on inflammatory biomarkers. Three cytokines (CRP, IL-6, TNF-α) with enough eligible studies (n = 6, 5 and 4, respectively) were selected for further meta-analyses. Data from these RCTs were pooled, and both overall effect and stratified subgroup analyses were performed. No relevant overall effects on peripheral CRP, IL-6 and TNF-α were observed. Subgroup analyses revealed a significant reduction in circulating CRP in participants with diagnosed diseases (SMD: -0.24, 95% CI: -0.49, 0.00) and IL-6 in females (SMD: -1.37, 95% CI: -1.93, -0.81), subjects with diagnosed diseases (SMD: -1.37, 95% CI: -1.93, -0.81) and with high-dose interventions (SMD: -0.69, 95% CI: -1.10, -0.38). In conclusion, consumption of quercetin is a promising therapeutic strategy for chronic disease management.
Key Findings
In conclusion, consumption of quercetin is a promising therapeutic strategy for chronic disease management.
Outcomes Measured
- C-reactive protein
- inflammatory markers
Population
| Field | Value |
|---|---|
| Population | diagnosed diseases |
| Sample Size | 6 |
| Age Range | See abstract |
| Condition | See abstract |
MeSH Terms
- Anti-Inflammatory Agents
- C-Reactive Protein
- Cytokines
- Dietary Supplements
- Humans
- Inflammation
- Quercetin
- Randomized Controlled Trials as Topic
Evidence Classification
- Level: Meta Analysis
- Publication Types: Journal Article, Meta-Analysis
- Vertical: quercetin
Provenance
- PMID: 31213101
- DOI: 10.1080/09637486.2019.1627515
- PMCID: Not in PMC
- Verified: 2026-04-09 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-09